[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Global Dopamine Agonists Market Research Report 2016-2026

December 2021 | 75 pages | ID: G95F45FC6A9BEN
HeyReport

US$ 1,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SUMMARY

The global Dopamine Agonists market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • Ergotamine
  • Non-ergotamine
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Pfizer
  • GSK
  • Roche
  • Merck
  • UCB
  • Teva Pharmaceutical Industries Ltd
  • ACADIA Pharmaceuticals Inc
  • Impax Laboratories
  • AbbVie
  • Boehringer Ingelheim
  • Otsuka Pharmaceutical Co
  • Kissei Pharmaceutical Co
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Parkinson's
  • Restless Legs Syndrome
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
Figure Dopamine Agonists Picture
  1.1.2 Specifications
Table Product Specifications of Dopamine Agonists
1.2 Market Segment
  1.2.1 by Type
Table Products Segment of Dopamine Agonists
Table Global Dopamine Agonists Market by Type, 2016-2026 (USD Million)
    1.2.1.1 Ergotamine
Table Ergotamine Overview
    1.2.1.2 Non-ergotamine
Table Non-ergotamine Overview
  1.2.2 by Application
Table Application Segment of Dopamine Agonists
Table Global Dopamine Agonists Market by Application, 2016-2026 (USD Million)
    1.2.2.1 Parkinson's
Table Parkinson's Overview
    1.2.2.2 Restless Legs Syndrome
Table Restless Legs Syndrome Overview
  1.2.3 by Regions
Table Global Dopamine Agonists Market by Region, 2016-2026 (USD Million)

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
Figure Industry Chain Structure of Dopamine Agonists
2.2 Upstream
Table Cost of Dopamine Agonists
Figure Manufacturing Process of Dopamine Agonists
2.3 Market
  2.3.1 SWOT
Figure SWOT of Dopamine Agonists
  2.3.2 Dynamics
Table Market Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
Table Policy of Dopamine Agonists
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Dopamine Agonists
3.4 Market Entry
Table Market Entry of Dopamine Agonists

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 Ergotamine Market, 2016-2020
Figure Ergotamine Market Size and Growth, 2016-2020 (USD Million)
Figure Ergotamine Market Size and Growth, 2016-2020 (in Volume)
Table Ergotamine CAGR by Revenue and Volume, 2016-2020
  4.1.2 Non-ergotamine Market, 2016-2020
Figure Non-ergotamine Market Size and Growth, 2016-2020 (USD Million)
Figure Non-ergotamine Market Size and Growth, 2016-2020 (in Volume)
Table Non-ergotamine CAGR by Revenue and Volume, 2016-2020
4.2 Market Forecast
  4.2.1 Ergotamine Market Forecast, 2021-2026
Figure Ergotamine Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Ergotamine Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Ergotamine CAGR by Revenue and Volume, 2016-2026
  4.2.2 Non-ergotamine Market Forecast, 2021-2026
Figure Non-ergotamine Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Non-ergotamine Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Non-ergotamine CAGR by Revenue and Volume, 2016-2026

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Parkinson's Market, 2016-2020
Figure Parkinson's Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Parkinson's CAGR by Revenue and Volume, 2016-2020
  5.1.2 Restless Legs Syndrome Market, 2016-2020
Figure Restless Legs Syndrome Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Table Restless Legs Syndrome CAGR by Revenue and Volume, 2016-2020
5.2 Market Forecast
  5.2.1 Parkinson's Market Forecast, 2021-2026
Figure Parkinson's Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Parkinson's Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Parkinson's CAGR by Revenue and Volume, 2021-2026
  5.2.2 Restless Legs Syndrome Market Forecast, 2021-2026
Figure Restless Legs Syndrome Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Restless Legs Syndrome Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Restless Legs Syndrome CAGR by Revenue and Volume, 2021-2026

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2016-2020
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
    6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
    6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2016-2020
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Table North America CAGR by Revenue and Volume, 2016-2020
    6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
    6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2016-2020
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Table Europe CAGR by Revenue and Volume, 2016-2020
    6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
    6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2016-2020
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Table South America CAGR by Revenue and Volume, 2016-2020
    6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
    6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2016-2020
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
    6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
    6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2021-2026
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
  6.2.2 North America Market Forecast, 2021-2026
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table North America CAGR by Revenue and Volume, 2021-2026
  6.2.3 Europe Market Forecast, 2021-2026
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Europe CAGR by Revenue and Volume, 2021-2026
  6.2.4 South America Market Forecast, 2021-2026
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Table South America CAGR by Revenue and Volume, 2021-2026
  6.2.5 Middle East & Africa Market Forecast, 2021-2026
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
Table Global Dopamine Agonists Market by Vendors, 2016-2020 (in Volume)
Table Global Dopamine Agonists Market Share by Vendors, 2016-2020 (USD Million)
Table Global Dopamine Agonists Market Share by Vendors, 2016-2020 (in Volume)
7.2 Market Concentration
Figure Dopamine Agonists Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview

8 MAJOR VENDORS

8.1 Pfizer
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 GSK
Table GSK Profile List
Table Microecological Modulator Operating Data of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Roche
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 Merck
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 UCB
Table UCB Profile List
Table Microecological Modulator Operating Data of UCB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Teva Pharmaceutical Industries Ltd
Table Teva Pharmaceutical Industries Ltd Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 ACADIA Pharmaceuticals Inc
Table ACADIA Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of ACADIA Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Impax Laboratories
Table Impax Laboratories Profile List
Table Microecological Modulator Operating Data of Impax Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 AbbVie
Table AbbVie Profile List
Table Microecological Modulator Operating Data of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Boehringer Ingelheim
Table Boehringer Ingelheim Profile List
Table Microecological Modulator Operating Data of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 Otsuka Pharmaceutical Co
Table Otsuka Pharmaceutical Co Profile List
Table Microecological Modulator Operating Data of Otsuka Pharmaceutical Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 Kissei Pharmaceutical Co
Table Kissei Pharmaceutical Co Profile List
Table Microecological Modulator Operating Data of Kissei Pharmaceutical Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

9 CONCLUSION

LIST OF TABLES

Table Product Specifications of Dopamine Agonists
Table Products Segment of Dopamine Agonists
Table Global Dopamine Agonists Market by Type, 2016-2026 (USD Million)
Table Ergotamine Overview
Table Non-ergotamine Overview
Table Application Segment of Dopamine Agonists
Table Global Dopamine Agonists Market by Application, 2016-2026 (USD Million)
Table Parkinson's Overview
Table Restless Legs Syndrome Overview
Table Global Dopamine Agonists Market by Region, 2016-2026 (USD Million)
Table Cost of Dopamine Agonists
Table Market Dynamics
Table Policy of Dopamine Agonists
Table GDP of Major Countries
Table Technology of Dopamine Agonists
Table Market Entry of Dopamine Agonists
Table Ergotamine CAGR by Revenue and Volume, 2016-2020
Table Non-ergotamine CAGR by Revenue and Volume, 2016-2020
Table Ergotamine CAGR by Revenue and Volume, 2016-2026
Table Non-ergotamine CAGR by Revenue and Volume, 2016-2026
Table Parkinson's CAGR by Revenue and Volume, 2016-2020
Table Restless Legs Syndrome CAGR by Revenue and Volume, 2016-2020
Table Parkinson's CAGR by Revenue and Volume, 2021-2026
Table Restless Legs Syndrome CAGR by Revenue and Volume, 2021-2026
Table Asia-Pacific CAGR by Revenue and Volume, 2016-2020
Table North America CAGR by Revenue and Volume, 2016-2020
Table Europe CAGR by Revenue and Volume, 2016-2020
Table South America CAGR by Revenue and Volume, 2016-2020
Table Middle East & Africa CAGR by Revenue and Volume, 2016-2020
Table Asia-Pacific CAGR by Revenue and Volume, 2021-2026
Table North America CAGR by Revenue and Volume, 2021-2026
Table Europe CAGR by Revenue and Volume, 2021-2026
Table South America CAGR by Revenue and Volume, 2021-2026
Table Middle East & Africa CAGR by Revenue and Volume, 2021-2026
Table Global Dopamine Agonists Market by Vendors, 2016-2020 (in Volume)
Table Global Dopamine Agonists Market Share by Vendors, 2016-2020 (USD Million)
Table Global Dopamine Agonists Market Share by Vendors, 2016-2020 (in Volume)
Table Price Factors List
Table Pfizer Profile List
Table Microecological Modulator Operating Data of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table GSK Profile List
Table Microecological Modulator Operating Data of GSK (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Roche Profile List
Table Microecological Modulator Operating Data of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck Profile List
Table Microecological Modulator Operating Data of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table UCB Profile List
Table Microecological Modulator Operating Data of UCB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Teva Pharmaceutical Industries Ltd Profile List
Table Microecological Modulator Operating Data of Teva Pharmaceutical Industries Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table ACADIA Pharmaceuticals Inc Profile List
Table Microecological Modulator Operating Data of ACADIA Pharmaceuticals Inc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Impax Laboratories Profile List
Table Microecological Modulator Operating Data of Impax Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table AbbVie Profile List
Table Microecological Modulator Operating Data of AbbVie (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Boehringer Ingelheim Profile List
Table Microecological Modulator Operating Data of Boehringer Ingelheim (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Otsuka Pharmaceutical Co Profile List
Table Microecological Modulator Operating Data of Otsuka Pharmaceutical Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kissei Pharmaceutical Co Profile List
Table Microecological Modulator Operating Data of Kissei Pharmaceutical Co (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)


LIST OF FIGURES

Figure Dopamine Agonists Picture
Figure Industry Chain Structure of Dopamine Agonists
Figure Manufacturing Process of Dopamine Agonists
Figure SWOT of Dopamine Agonists
Figure Ergotamine Market Size and Growth, 2016-2020 (USD Million)
Figure Ergotamine Market Size and Growth, 2016-2020 (in Volume)
Figure Non-ergotamine Market Size and Growth, 2016-2020 (USD Million)
Figure Non-ergotamine Market Size and Growth, 2016-2020 (in Volume)
Figure Ergotamine Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Ergotamine Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Non-ergotamine Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Non-ergotamine Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Parkinson's Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Figure Restless Legs Syndrome Market Size and Growth, 2016-2020 (USD Million)
Figure Market Size and Growth, 2016-2020 (in Volume)
Figure Parkinson's Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Parkinson's Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Restless Legs Syndrome Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Restless Legs Syndrome Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2016-2020 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2016-2020 (USD Million)
Figure North America Market Size and Growth, 2016-2020 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2016-2020 (USD Million)
Figure Europe Market Size and Growth, 2016-2020 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2016-2020 (USD Million)
Figure South America Market Size and Growth, 2016-2020 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2016-2020 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2016-2020 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure North America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure North America Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Europe Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Europe Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure South America Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure South America Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2021-2026 (in Volume)
Figure Dopamine Agonists Market Concentration by Region
Figure Marketing Channels Overview

More Publications

Need Help?

Ask a Question

Market Reports

All Categories